Central LIF gene therapy suppresses food intake, body weight, serum leptin and insulin for extended periods
- 4 April 2002
- Vol. 23 (5) , 975-984
- https://doi.org/10.1016/s0196-9781(02)00021-9
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Dose-Dependent Effects of Central Leptin Gene Therapy on Genes That Regulate Body Weight and Appetite in the HypothalamusMolecular Therapy, 2001
- Neuropeptide Y Counteracts the Anorectic and Weight Reducing Effects of Ciliary Neurotropic FactorJournal of Neuroendocrinology, 2000
- Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine FunctionEndocrine Reviews, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body WeightEndocrine Reviews, 1999
- Disruption of the Relationship between Fat Content and Leptin Levels with Aging in HumansJournal of Clinical Endocrinology & Metabolism, 1998
- Anorectic Effects of the Cytokine, Ciliary Neurotropic Factor, Are Mediated by Hypothalamic Neuropeptide Y: Comparison with LeptinEndocrinology, 1998
- Interleukin 6 and its Receptor: Ten Years LaterInternational Reviews of Immunology, 1998
- In vivoEffect of Recombinant Human Leukemia Inhibitory Factor in PrimatesJapanese Journal of Cancer Research, 1997
- Thermogenesis and Thyroid FunctionAnnual Review of Nutrition, 1995